iBio, Inc.
IBIO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $14 | $7 | $23 |
| Short-Term Investments | $0 | $0 | $0 | $11 |
| Receivables | $0 | $1 | $0 | $6 |
| Inventory | $0 | $0 | $0 | $4 |
| Other Curr. Assets | $1 | $1 | $19 | $2 |
| Total Curr. Assets | $10 | $16 | $26 | $45 |
| Property Plant & Equip (Net) | $5 | $6 | $8 | $42 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $7 | $5 | $5 | $5 |
| Long-Term Investments | $1 | $0 | $2 | $8 |
| Tax Assets | $0 | $0 | $0 | -$8 |
| Other NC Assets | $0 | $1 | $0 | $8 |
| Total NC Assets | $13 | $13 | $15 | $54 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $23 | $29 | $41 | $99 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $2 | $4 |
| Short-Term Debt | $1 | $1 | $14 | $22 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $2 | $6 | $4 |
| Total Curr. Liab. | $6 | $4 | $22 | $30 |
| LT Debt | $2 | $4 | $3 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $2 |
| Total NC Liab. | $2 | $4 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $4 |
| Total Liabilities | $8 | $7 | $26 | $36 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$332 | -$314 | -$289 | -$224 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $347 | $335 | $304 | $288 |
| Total Equity | $15 | $21 | $15 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $23 | $29 | $41 | $99 |
| Net Debt | -$5 | -$10 | $10 | $3 |